Clinical Pharmacology and Drug Toxicity Practice Questions

Q: Isoniazid-induced peripheral neuropathy results from a deficiency of which vitamin?

Vitamin B6. **Explanation:** **Mechanism of Action (Why C is correct):** Isoniazid (INH) is a primary antitubercular drug that induces peripheral neuropathy through two main mechanisms involving **Pyridoxine (Vitamin B6)**. [1] 1. **Chemical Interaction:** INH reacts with pyridoxal phosphate (the active form of B6) to form pyridoxal-isoniazid hydrazones, which are excreted in the urine. 2. **Enzyme Inhibition:** INH inhibits the enzyme **pyridoxine phosphokinase**, which is essential for converting pyridoxine into its active form, pyridoxal phosphate. Pyridoxal phosphate is a vital cofactor for neurotransmitter synthesis; its deficiency leads to axonal degeneration and subsequent "glove and stocking" neuropathy [1]. **Analysis of Incorrect Options:** * **A. Vitamin B1 (Thiamine):** Deficiency causes Beriberi (Dry/Wet) and Wernicke-Korsakoff syndrome, typically seen in chronic alcoholism, not INH therapy. * **B. Vitamin B2 (Riboflavin):** Deficiency leads to cheilosis, glossitis, and corneal vascularization. * **D. Vitamin B12 (Cyanocobalamin):** Deficiency causes Megaloblastic anemia and Subacute Combined Degeneration (SCD) of the spinal cord. **High-Yield Clinical Pearls for NEET-PG:** * **Prophylaxis:** To prevent neuropathy, **10–50 mg/day** of Pyridoxine is co-administered with INH [1]. * **Risk Factors:** Slow acetylators, malnourished individuals, diabetics, and chronic alcoholics are at a higher risk of INH-induced toxicity [1]. * **Sideroblastic Anemia:** INH can also cause microcytic anemia because Vitamin B6 is a cofactor for **ALA synthase**, the rate-limiting enzyme in heme synthesis. * **Other B6-Interacting Drugs:** Hydralazine, Penicillamine, and Cycloserine can also cause B6 deficiency.

Q: Drug-induced colitis is most frequently associated with which drug?

Clindamycin. **Explanation:** **1. Why Clindamycin is correct:** Clindamycin is the classic drug associated with **Pseudomembranous Colitis (PMC)**. The underlying mechanism involves the suppression of normal protective gut flora (especially anaerobes), which allows the overgrowth of the toxin-producing bacterium ***Clostridioides difficile*** (formerly *Clostridium difficile*). These toxins (Toxin A and B) cause mucosal inflammation and the formation of characteristic "pseudomembranes" (yellow-white plaques) on the colonic mucosa. While many broad-spectrum antibiotics (like Cephalosporins and Fluoroquinolones) can cause PMC, Clindamycin carries the highest relative risk per dose. **2. Why the other options are incorrect:** * **Neomycin:** This is an aminoglycoside primarily used for bowel preparation or hepatic encephalopathy. It is poorly absorbed from the gut and is more likely to cause malabsorption syndromes rather than colitis. * **Vancomycin:** Oral Vancomycin is actually the **drug of choice** for treating *C. difficile* colitis. It is not a cause of the condition because it is highly effective against the causative Gram-positive anaerobe. * **Chloramphenicol:** This drug is most notoriously associated with bone marrow suppression (Aplastic anemia) and Gray Baby Syndrome, not colitis. **3. Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Oral **Vancomycin** or **Fidaxomicin** are first-line treatments for PMC. Metronidazole is now reserved for mild cases or when other options are unavailable. * **Diagnosis:** The most common diagnostic test is the detection of *C. difficile* toxins in the stool via ELISA or PCR. * **Gold Standard Diagnosis:** Sigmoidoscopy/Colonoscopy showing characteristic pseudomembranes. * **High-Yield Association:** While Clindamycin has the highest *relative* risk, **Cephalosporins** are the most common *absolute* cause in clinical practice due to their higher frequency of use.

Q: Which of the following drugs does NOT cause hyperuricemia?

Probenecid. ### Explanation The correct answer is **Probenecid**. **1. Why Probenecid is the correct answer:** Hyperuricemia (elevated serum uric acid) occurs when drugs either increase uric acid production or, more commonly, decrease its renal excretion. **Probenecid** is a **uricosuric agent**. It works by inhibiting the **URAT1** transporter in the proximal convoluted tubule, which prevents the reabsorption of uric acid from the urine back into the blood. Consequently, it *lowers* serum uric acid levels and is used in the chronic management of gout. **2. Why the other options are incorrect:** * **Thiazide Diuretics:** These drugs cause hyperuricemia by two mechanisms: they compete with uric acid for the organic acid secretory system in the kidney and cause volume depletion, which enhances proximal tubular reabsorption of uric acid. * **Pyrazinamide:** A key component of anti-tubercular therapy (ATT), its metabolite (pyrazinoic acid) inhibits the secretion of uric acid into the tubular lumen, frequently leading to asymptomatic hyperuricemia. * **Ethambutol:** Another ATT drug that interferes with the renal excretion of urates, often causing a rise in serum uric acid levels. **3. Clinical Pearls for NEET-PG:** * **Mnemonic for Hyperuricemia (CANT):** **C**yclosporine, **A**lcohol, **N**iacin, **T**hiazides/Teriparatide. * **Anti-TB Drugs:** Both Pyrazinamide and Ethambutol cause hyperuricemia; however, Pyrazinamide is a more potent inducer. * **Aspirin Paradox:** Low-dose aspirin ( 4g/day) is uricosuric. * **Drug of Choice:** For acute gout, NSAIDs are preferred; for chronic gout, Allopurinol (Xanthine oxidase inhibitor) is the first-line agent.

Q: All are features of lead poisoning, except?

Diarrhea. **Explanation:** Lead poisoning (Plumbism) is a multisystemic disorder. The correct answer is **Diarrhea** because lead poisoning typically causes **constipation**, not diarrhea. **1. Why Diarrhea is the correct answer (The "Except"):** Lead toxicity affects the gastrointestinal smooth muscles, leading to intestinal spasms. This manifests clinically as severe, poorly localized abdominal spasms known as **Lead Colic**. This condition is characteristically associated with obstinate **constipation** rather than diarrhea. **2. Analysis of Incorrect Options:** * **Abdominal Pain:** As mentioned, "Lead Colic" is one of the most common presenting symptoms in both acute and chronic exposure. * **Encephalopathy:** This is a severe manifestation, more common in children. It presents with cerebral edema, increased intracranial pressure, seizures, and coma. It is a medical emergency. * **Nephropathy:** Chronic lead exposure leads to "Lead Nephropathy," characterized by proximal tubular damage (Fanconi-like syndrome), interstitial fibrosis, and hyperuricemia (leading to "Saturnine Gout"). **3. High-Yield Clinical Pearls for NEET-PG:** * **Hematology:** Microcytic hypochromic anemia with **Basophilic Stippling** (due to inhibition of 1,2-pyrimidine 5'-nucleotidase). * **Enzymes Inhibited:** ALA dehydratase and Ferrochelatase (leading to increased Coproporphyrin III and Erythrocyte Protoporphyrin). * **Physical Sign:** **Burtonian Line** (a bluish-purple line on the gingival margin). * **Radiology:** "Lead lines" (increased density) at the metaphyses of long bones in children. * **Treatment:** * Adults: Oral Succimer (DMSA) or parenteral CaNa₂EDTA. * Children/Encephalopathy: Dimercaprol (BAL) followed by EDTA.

Q: Which of the following is not typically monitored in a patient receiving Methotrexate therapy?

Eye examination. **Explanation:** Methotrexate (MTX) is a folate antagonist that inhibits dihydrofolate reductase (DHFR), leading to interference with DNA synthesis. While it is a cornerstone in treating malignancies and autoimmune conditions (like Rheumatoid Arthritis), it carries a significant profile of multisystem toxicities that necessitate stringent monitoring. **Why Eye Examination is the Correct Answer:** Unlike drugs such as Hydroxychloroquine (which requires baseline and periodic fundoscopy for retinopathy) or Ethambutol (optic neuritis), **Methotrexate is not associated with significant ocular toxicity.** Therefore, routine eye examinations are not a standard part of the MTX monitoring protocol. **Why the other options are monitored:** * **Hemogram (D):** MTX causes **bone marrow suppression** (myelosuppression), leading to leucopenia, thrombocytopenia, and macrocytic anemia. Frequent CBC counts are mandatory. * **Liver Function Tests (A):** Chronic use can lead to **hepatotoxicity**, ranging from elevated transaminases to hepatic fibrosis and cirrhosis. Baseline and periodic LFTs are essential. * **Lung Function Tests (B):** MTX can cause idiosyncratic **interstitial pneumonitis** or pulmonary fibrosis. Baseline chest X-rays and monitoring for respiratory symptoms (dry cough, dyspnea) are required. **High-Yield Clinical Pearls for NEET-PG:** * **Rescue Therapy:** **Leucovorin (Folinic acid)** is used to "rescue" normal cells from MTX toxicity by bypassing the inhibited DHFR enzyme. * **Excretion:** MTX is primarily excreted by the kidneys; thus, renal function (Creatinine) must also be monitored to prevent toxic accumulation. * **Contraindication:** It is highly **teratogenic** (Neural tube defects) and contraindicated in pregnancy. * **Acute Toxicity:** High doses can cause **mucositis** and crystals in the urine (crystalluria).

Q: Forced alkaline diuresis is effective in the management of poisoning by which of the following agents?

Phenobarbitone. **Explanation:** The correct answer is **Phenobarbitone**. **Mechanism of Forced Alkaline Diuresis (FAD):** The principle behind FAD is **ion trapping**. Phenobarbitone is a **weakly acidic drug**. By administering intravenous sodium bicarbonate, the urine is alkalinized (pH > 7.5). In an alkaline medium, acidic drugs become ionized (polar). Since ionized molecules cannot easily cross the lipid membrane of the renal tubules, their reabsorption back into the bloodstream is prevented, thereby "trapping" them in the urine and enhancing their excretion. FAD is also effective for **Salicylates (Aspirin)**. **Analysis of Incorrect Options:** * **B. Lead:** Heavy metal poisoning is managed with **chelating agents** like Calcium disodium EDTA, Succimer (DMSA), or Penicillamine. * **C. Iron:** Acute iron toxicity is treated with the specific chelator **Deferoxamine**. FAD has no role as iron does not exist as a simple weak acid in the blood. * **D. Organophosphates:** These inhibit acetylcholinesterase. Management involves **Atropine** (muscarinic antagonist) and **Pralidoxime** (enzyme reactivator). **High-Yield Clinical Pearls for NEET-PG:** 1. **Forced Acidic Diuresis:** Historically used for weak bases (e.g., Amphetamines, Quinine), it is **no longer recommended** due to the risk of precipitating acute renal failure from myoglobinuria. 2. **Prerequisites for FAD:** The drug must be primarily excreted by the kidneys and have a low volume of distribution ($V_d$). 3. **Complications:** Monitor for hypokalemia, pulmonary edema, and metabolic alkalosis during FAD. 4. **Specific Antidote:** For Phenobarbitone, there is no specific pharmacological antagonist; management is supportive plus FAD or Hemodialysis in severe cases.

Q: Sibutramine is used for:

Obesity. **Explanation:** **Sibutramine** is a centrally acting drug formerly used in the management of **Obesity**. It functions as a **Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)**. By inhibiting the reuptake of these neurotransmitters in the hypothalamus, it enhances satiety (feeling of fullness) and increases metabolic rate, thereby facilitating weight loss. **Analysis of Options:** * **Option D (Correct):** Sibutramine was FDA-approved for long-term obesity management. However, it is important to note that it was **withdrawn** from many global markets (including India and the USA) in 2010 due to an increased risk of non-fatal cardiovascular events like strokes and myocardial infarction (SCOUT trial). * **Option A (Hemorrhage):** Sibutramine has no role in hemostasis. In fact, due to its sympathomimetic effects, it can increase blood pressure. * **Option B (Nasal Decongestant):** While some sympathomimetics (like Pseudoephedrine) are used as decongestants, Sibutramine’s specific action on satiety centers makes it unsuitable for this purpose. * **Option C (Diabetes):** While weight loss can improve Type 2 Diabetes, Sibutramine is not a primary treatment for hyperglycemia. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** SNRI (increases satiety). * **Status:** Banned/Withdrawn due to **cardiovascular toxicity**. * **Current Anti-obesity Drugs:** * **Orlistat:** Gastric/pancreatic lipase inhibitor (causes steatorrhea). * **Lorcaserin:** 5-HT2C agonist (also withdrawn in some regions). * **Liraglutide/Semaglutide:** GLP-1 receptor agonists (currently preferred). * **Phentermine + Topiramate:** Combination therapy.

Q: What is the primary antidote for paracetamol poisoning?

N-acetylcysteine. ### Explanation **1. Why N-acetylcysteine (NAC) is the Correct Answer:** Paracetamol (Acetaminophen) is normally metabolized in the liver. A small portion is converted by Cytochrome P450 (CYP2E1) into a highly reactive toxic metabolite called **NAPQI** (*N-acetyl-p-benzoquinone imine*). In therapeutic doses, NAPQI is neutralized by **Glutathione**. In toxicity, glutathione stores are depleted, leading to NAPQI-induced hepatic necrosis. **N-acetylcysteine (NAC)** acts as the specific antidote by: * Serving as a precursor for glutathione synthesis. * Directly binding to and detoxifying NAPQI. * Improving oxygen delivery and acting as an antioxidant in late stages. **2. Analysis of Incorrect Options:** * **B. Activated Charcoal:** While used for gastric decontamination if the patient presents within 1–2 hours of ingestion, it is not the *antidote*. It prevents absorption but does not treat the systemic toxicity already present. * **C. Dialysis:** Paracetamol has a large volume of distribution and is not effectively removed by hemodialysis. It is only considered in extreme cases of renal failure or massive overdose (levels >1000 mg/L). * **D. Alkaline Diuresis:** This is used for acidic drugs like Salicylates or Phenobarbitone to enhance urinary excretion. It has no role in paracetamol poisoning. **3. NEET-PG High-Yield Clinical Pearls:** * **Rumack-Matthew Nomogram:** Used to determine the need for NAC treatment based on plasma paracetamol levels at or after **4 hours** post-ingestion. * **Timing:** NAC is most effective (nearly 100% hepatoprotective) if administered within **8–10 hours** of ingestion. * **Dosage:** The traditional IV protocol (Prescott) lasts 21 hours, while the oral protocol lasts 72 hours. * **Side Effect:** IV NAC can cause **Anaphylactoid reactions** (non-IgE mediated histamine release); management involves slowing the infusion and giving antihistamines.

Q: Which one of the following drugs is the most common cause of progressive multifocal leukoencephalopathy?

Natalizumab. **Explanation:** **Progressive Multifocal Leukoencephalopathy (PML)** is a rare, often fatal demyelinating disease of the CNS caused by the reactivation of the **JC virus** (John Cunningham virus). This occurs almost exclusively in immunocompromised individuals or those on specific immunomodulatory therapies. **Why Natalizumab is the correct answer:** Natalizumab is a monoclonal antibody against **$\alpha$4-integrin**. By blocking this integrin, it prevents leukocytes from crossing the blood-brain barrier (BBB) to enter the CNS. While this is effective in treating **Multiple Sclerosis (MS)** and Crohn’s disease by reducing inflammation, it creates a state of "localized immune surveillance deficiency" in the brain. This allows the latent JC virus to replicate unchecked, making Natalizumab the drug most strongly and commonly associated with PML. **Analysis of Incorrect Options:** * **Rituximab (Anti-CD20):** While Rituximab is the second most common monoclonal antibody associated with PML (often in patients with hematological malignancies or SLE), the statistical risk and direct association are significantly higher with Natalizumab. * **Cetuximab (Anti-EGFR):** Used in colorectal and head/neck cancers; it is not typically associated with PML. * **Bevacizumab (Anti-VEGF):** An angiogenesis inhibitor used in various cancers; it does not significantly impair T-cell surveillance in the CNS and is not a cause of PML. **High-Yield Clinical Pearls for NEET-PG:** * **Black Box Warning:** Natalizumab has a boxed warning for PML. * **Risk Stratification:** The risk of PML increases with the duration of treatment (especially >2 years), prior use of immunosuppressants, and positive **anti-JCV antibody status**. * **Clinical Presentation:** Patients present with subacute neurological deficits (altered mental status, visual loss, or motor weakness) and MRI showing multifocal white matter lesions without mass effect.

Q: Quinine-induced thrombocytopenia is:

Antibody-mediated. ### Explanation **Correct Answer: A. Antibody-mediated** Quinine-induced thrombocytopenia (QITP) is a classic example of **drug-induced immune thrombocytopenia (DITP)**. The mechanism involves the formation of **drug-dependent antibodies** (usually IgG or IgM). These antibodies bind to specific glycoproteins on the platelet surface (most commonly **GPIb/IX** or **GPIIb/IIIa**) only in the presence of the drug. This binding leads to platelet destruction by the reticuloendothelial system, causing a rapid and severe drop in platelet counts. **Why other options are incorrect:** * **B. Dose-related toxicity:** QITP is not related to the plasma concentration of the drug. Even minute amounts (e.g., "tonic water" ingestion) can trigger a massive immune response in sensitized individuals. * **C. Idiosyncratic reaction:** While the reaction is unpredictable, "Antibody-mediated" is a more specific and accurate description of the underlying pathophysiology. In pharmacology exams, always choose the specific mechanism over a general term. * **D. Inhibits production of platelets:** Quinine causes peripheral destruction of mature platelets rather than suppressing their production in the bone marrow (unlike drugs like linezolid or chemotherapy). **High-Yield Clinical Pearls for NEET-PG:** * **Cinchonism:** The most common side effect of Quinine, characterized by tinnitus, high-frequency hearing loss, dizziness, and blurred vision. * **Blackwater Fever:** A severe complication of Quinine/Malaria causing massive intravascular hemolysis and hemoglobinuria. * **Hypoglycemia:** Quinine stimulates pancreatic beta cells to release insulin; monitor blood glucose during IV administration. * **QT Prolongation:** Quinine has class 1A antiarrhythmic-like properties and can cause Torsades de Pointes.

Question 1

Isoniazid-induced peripheral neuropathy results from a deficiency of which vitamin?

Accepted Answer

Vitamin B6

Answer

Vitamin B1

Answer

Vitamin B2

Answer

Vitamin B12

Question 2

Drug-induced colitis is most frequently associated with which drug?

Accepted Answer

Clindamycin

Answer

Neomycin

Answer

Vancomycin

Answer

Chloramphenicol

Question 3

Which of the following drugs does NOT cause hyperuricemia?

Accepted Answer

Probenecid

Answer

Thiazide

Answer

Pyrazinamide

Answer

Ethambutol

Question 4

All are features of lead poisoning, except?

Accepted Answer

Diarrhea

Answer

Abdominal pain

Answer

Encephalopathy

Answer

Nephropathy

Question 5

Which of the following is not typically monitored in a patient receiving Methotrexate therapy?

Accepted Answer

Eye examination

Answer

Liver function tests

Answer

Lung function tests

Answer

Hemogram

Question 6

Forced alkaline diuresis is effective in the management of poisoning by which of the following agents?

Accepted Answer

Phenobarbitone

Answer

Lead

Answer

Iron

Answer

Organophosphates

Question 7

Sibutramine is used for:

Accepted Answer

Obesity

Answer

Hemorrhage

Answer

Nasal decongestant

Answer

Diabetes

Question 8

What is the primary antidote for paracetamol poisoning?

Accepted Answer

N-acetylcysteine

Answer

Activated charcoal

Answer

Dialysis

Answer

Alkaline diuresis

Question 9

Which one of the following drugs is the most common cause of progressive multifocal leukoencephalopathy?

Accepted Answer

Natalizumab

Answer

Cetuximab

Answer

Rituximab

Answer

Bevacizumab

Question 10

Quinine-induced thrombocytopenia is:

Accepted Answer

Antibody-mediated

Answer

Dose-related toxicity

Answer

Idiosyncratic reaction

Answer

Inhibits production of platelets

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?